Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darell D Bigner

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Nuclear Medicine and Biology|January 12, 2002
Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoateGanesan Vaidyanathan, Donna J Affleck, Darell D Bigner, et al.
Radiation Research|April 7, 2011
Medical diagnostic radiation exposures and risk of gliomasFaith Davis, Dora Il'yasova, Kristin Rankin, et al.
Oncoimmunology|June 5, 2013
A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous systemBryan D Choi, Ira Pastan, Darell D Bigner, et al.
Nuclear Medicine and Biology|May 28, 2003
N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211AtGanesan Vaidyanathan, Donna J Affleck, Darell D Bigner, et al.
Cancer Science|August 8, 2009
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfacesMichael W Graner, Deborah A Raynes, Darell D Bigner, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2007
O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell linesStewart P Johnson, Barton A Kamen, Darell D Bigner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Recent advances in the treatment of malignant astrocytomaDavid A Reardon, Jeremy N Rich, Henry S Friedman, et al.
Journal of Neurosurgery|February 5, 2008
Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigationRyan T Mott, Kristi C Turner, Darell D Bigner, et al.
Drugs of the Future|February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolyticPatrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Nuclear Medicine and Biology|February 7, 2006
Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearanceSriram Shankar, Ganesan Vaidyanathan, Chien-Tsun Kuan, et al.
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Nuclear Medicine and Biology|January 12, 2002
Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoateGanesan Vaidyanathan, Donna J Affleck, Darell D Bigner, et al.
Radiation Research|April 7, 2011
Medical diagnostic radiation exposures and risk of gliomasFaith Davis, Dora Il'yasova, Kristin Rankin, et al.
Oncoimmunology|June 5, 2013
A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous systemBryan D Choi, Ira Pastan, Darell D Bigner, et al.
Nuclear Medicine and Biology|May 28, 2003
N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with alpha-particle emitting 211AtGanesan Vaidyanathan, Donna J Affleck, Darell D Bigner, et al.
Cancer Science|August 8, 2009
Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfacesMichael W Graner, Deborah A Raynes, Darell D Bigner, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2007
O (4)-benzylfolic acid inactivates O (6)-alkylguanine-DNA alkyltransferase in brain tumor cell linesStewart P Johnson, Barton A Kamen, Darell D Bigner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2006
Recent advances in the treatment of malignant astrocytomaDavid A Reardon, Jeremy N Rich, Henry S Friedman, et al.
Journal of Neurosurgery|February 5, 2008
Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas. Laboratory investigationRyan T Mott, Kristi C Turner, Darell D Bigner, et al.
Drugs of the Future|February 10, 2015
Rindopepimut: anti-EGFRvIII peptide vaccine, oncolyticPatrick C Gedeon, Bryan D Choi, John H Sampson, et al.
Nuclear Medicine and Biology|February 7, 2006
Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearanceSriram Shankar, Ganesan Vaidyanathan, Chien-Tsun Kuan, et al.
Pageof 25